These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 23073062)
1. Thrombotic thrombocytopenic purpura due to anti-ADAMTS13 antibodies in multiple myeloma. Yao H; Monge M; Renou M; Lecaque C; Jauréguy M; Presne C; Makdassi R; Choukroun G Clin Nephrol; 2014 Mar; 81(3):210-5. PubMed ID: 23073062 [TBL] [Abstract][Full Text] [Related]
2. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. Tsai HM; Lian EC N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246 [TBL] [Abstract][Full Text] [Related]
3. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other? Shibagaki Y; Fujita T Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259 [TBL] [Abstract][Full Text] [Related]
4. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura. Thomas MR; de Groot R; Scully MA; Crawley JT EBioMedicine; 2015 Aug; 2(8):942-52. PubMed ID: 26425702 [TBL] [Abstract][Full Text] [Related]
5. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285 [TBL] [Abstract][Full Text] [Related]
6. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura. Starke R; Machin S; Scully M; Purdy G; Mackie I Br J Haematol; 2007 Feb; 136(4):649-55. PubMed ID: 17367414 [TBL] [Abstract][Full Text] [Related]
7. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies. Bresin E; Gastoldi S; Daina E; Belotti D; Pogliani E; Perseghin P; Scalzulli PR; Paolini R; Marcenò R; Remuzzi G; Galbusera M Thromb Haemost; 2009 Feb; 101(2):233-8. PubMed ID: 19190804 [TBL] [Abstract][Full Text] [Related]
8. ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura. Tsai HM; Raoufi M; Zhou W; Guinto E; Grafos N; Ranzurmal S; Greenfield RS; Rand JH Thromb Haemost; 2006 May; 95(5):886-92. PubMed ID: 16676082 [TBL] [Abstract][Full Text] [Related]
9. Pregnancy-associated thrombotic thrombocytopenic purpura. Gerth J; Schleussner E; Kentouche K; Busch M; Seifert M; Wolf G Thromb Haemost; 2009 Feb; 101(2):248-51. PubMed ID: 19190806 [TBL] [Abstract][Full Text] [Related]
10. Thrombotic thrombocytopenic purpura: proposal of a new pathogenic mechanism involving Helicobacter pylori infection. Franchini M Med Hypotheses; 2005; 65(6):1128-31. PubMed ID: 16084670 [TBL] [Abstract][Full Text] [Related]
11. A 9-month-old infant with acquired idiopathic thrombotic thrombocytopenic purpura caused by inhibitory IgG-autoantibody to ADAMTS13. Sato A; Hoshi Y; Onuma M; Sato R; Tsunematsu Y; Isonishi A; Matsumoto M; Fujimura Y; Imaizumi M Pediatr Hematol Oncol; 2010 Feb; 27(1):53-8. PubMed ID: 20121555 [TBL] [Abstract][Full Text] [Related]
12. The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura. Luken BM; Turenhout EA; Hulstein JJ; Van Mourik JA; Fijnheer R; Voorberg J Thromb Haemost; 2005 Feb; 93(2):267-74. PubMed ID: 15711742 [TBL] [Abstract][Full Text] [Related]
13. Novel recombinant glycosylphosphatidylinositol (GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura. Li D; Xiao J; Paessler M; Zheng XL Thromb Haemost; 2011 Nov; 106(5):947-58. PubMed ID: 21901237 [TBL] [Abstract][Full Text] [Related]
14. Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura. Ferrari S; Palavra K; Gruber B; Kremer Hovinga JA; Knöbl P; Caron C; Cromwell C; Aledort L; Plaimauer B; Turecek PL; Rottensteiner H; Scheiflinger F Haematologica; 2014 Apr; 99(4):779-87. PubMed ID: 24241492 [TBL] [Abstract][Full Text] [Related]
15. Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura. Yamaguchi Y; Moriki T; Igari A; Nakagawa T; Wada H; Matsumoto M; Fujimura Y; Murata M Thromb Res; 2011 Aug; 128(2):169-73. PubMed ID: 21496883 [TBL] [Abstract][Full Text] [Related]
16. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Zheng XL Annu Rev Med; 2015; 66():211-25. PubMed ID: 25587650 [TBL] [Abstract][Full Text] [Related]